SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-707467
Filing Date
2016-09-12
Accepted
2016-09-12 16:22:03
Documents
11
Period of Report
2016-09-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d234580d8k.htm 8-K 23637
2 EX-3.1 d234580dex31.htm EX-3.1 74202
3 EX-3.2 d234580dex32.htm EX-3.2 74093
4 EX-4.1 d234580dex41.htm EX-4.1 75063
5 EX-4.2 d234580dex42.htm EX-4.2 3742
6 EX-5.1 d234580dex51.htm EX-5.1 12757
7 EX-10.1 d234580dex101.htm EX-10.1 188846
8 EX-99.1 d234580dex991.htm EX-99.1 5718
9 GRAPHIC g234580dsp002.jpg GRAPHIC 207352
10 GRAPHIC g234580g09r09.jpg GRAPHIC 8008
11 GRAPHIC g234580g94v25.jpg GRAPHIC 457269
  Complete submission text file 0001193125-16-707467.txt   1386048
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 161881178
SIC: 2834 Pharmaceutical Preparations